The Economics of MedTech Innovation Balancing Patient Safety with Economic Growth
Fr. 252.00
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Gebundene Ausgabe
Erscheinungsdatum
12.06.2026
Abbildungen
schwarz-weiss Illustrationen, Zeichnungen, schwarz-weiss, Tabellen, schwarz-weiss
Verlag
Taylor and FrancisSeitenzahl
292
Maße (L/B/H)
23.4/15.6/1.8 cm
Gewicht
587 g
Sprache
Englisch
ISBN
978-1-04-128013-2
In an era where medical technology advances rapidly yet faces mounting regulatory hurdles, this book explores the critical interplay between patent law and regulatory frameworks that shapes the future of healthcare. It examines a fundamental problem in European medical technology innovation: the disconnect between patent protection periods and increasingly lengthy regulatory approval processes, demonstrating that Europe's current system forces companies to abandon breakthrough innovations in favor of incremental improvements. It compares the European Union's Medical Device Regulation with the United States' integrated patent-regulatory system, revealing how temporal misalignment between approval and protection discourages investment in complex medical devices. The book develops the first quantitative model linking patent-regulatory interaction and innovation effort in medical devices and demonstrates empirically, through Monte Carlo simulations and elasticity analysis, a significant improvement in development effort and increase in innovation value. It provides actionable policy guidance for aligning European patent law with regulatory timelines while maintaining high safety standards and offers cross-sectoral insights from renewable energy and biotechnology as benchmarks for successful regulatory-innovation alignment. Further, it addresses an urgent policy debate in the European Union concerning innovation incentives in the health-technology sector. By combining legal analysis, mathematical modelling, and policy evaluation, the book bridges law, economics, and health-technology governance. It provides a policy blueprint for balancing innovation incentives, regulatory efficiency, and patient safety, addressing a structural weakness at the heart of Europe's medtech competitiveness. With its quantitative rigour and policy relevance, the book targets a multidisciplinary readership of academics in law, economics, and innovation policy, policymakers, regulators at European Union institutions, and industry professionals.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.